LINEAR ALKYLBENZENE SULFONATE (LAS) - UNEP Chemicals
LINEAR ALKYLBENZENE SULFONATE (LAS) - UNEP Chemicals
LINEAR ALKYLBENZENE SULFONATE (LAS) - UNEP Chemicals
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
OECD SIDS <strong>LINEAR</strong> <strong>ALKYLBENZENE</strong> <strong>SULFONATE</strong> (<strong>LAS</strong>)<br />
Japanese); cited in: IPCS (1996); Environmental Health Criteria 169: Linear<br />
Alkylbenzene Sulfonates (<strong>LAS</strong>) and Related Compounds. WHO, Geneva,<br />
Switzerland.<br />
Reliability: 4 This study is assigned a reliability score of 4 because the original report<br />
was not available for review. However, the study was evaluated by IPCS<br />
prior to inclusion in their criteria document<br />
(r)<br />
Species/strain: rabbit/New Zealand white<br />
Sex: Female [X]; Male [ ]; Male/Female [ ]; No data [ ]<br />
Administration: Dermal<br />
Exposure period: 17 days (days 1 through 16 of gestation)<br />
Frequency of treatment: Daily<br />
Doses: 0.03, 0.3, or 3% (0.9, 9, or 90 mg/kg bw d)<br />
Control group: Yes [X]; No [ ]; No data [ ];<br />
Concurrent no treatment [X]; Concurrent vehicle [ ]; Historical [ ]<br />
NOAEL Maternal: 0.03% (0.9 mg/kg bw d)<br />
NOAEL teratogenicity: 3% (90 mg/kg bw d)<br />
Results: Maternal toxicity:<br />
At the high dose, local irritation was observed resulting in body weight loss<br />
and hypersensitivity (i.e., animals were increasingly irritable). The medium<br />
dose caused retarded body weight gain and hypersensitivity.<br />
Teratogenicity:<br />
At the medium and low dose, no differences were observed among the dose<br />
groups and the control group with respect to number of litters, viable young,<br />
litter weight, foetal weight, embryonic deaths, implantations, corpora lutea,<br />
pre and post implantation embryonic loss. The high dose was associated with<br />
slightly, but not significantly, higher foetal loss and lower litter size. The<br />
incidences of major malformations, minor visceral or skeletal anomalies, and<br />
skeletal variants were not different between controls and dose groups even at<br />
maternal toxic doses.<br />
Method: The dosage volume was 10 mL which was applied to an area of skin (12 x 20<br />
cm) from which the fur was removed. The nominal doses were 0.9, 9.0, and<br />
90 mg/kg bw/day. Thirteen rabbits per dose were used.<br />
GLP: Yes [ ] No [X] ? [ ]<br />
Test substance: <strong>LAS</strong><br />
Reference: Palmer, A.K., Readshaw, M.A. and Neuff, A.M. 1975b. Assessment of the<br />
teratogenic potential of surfactants (Part III) – Dermal application of <strong>LAS</strong><br />
and soap. Toxicology 4:171-181.<br />
Reliability: 2 Valid with restrictions<br />
5.10 OTHER RELEVANT INFORMATION<br />
(a)<br />
Type: Toxicokinetics<br />
Results:<br />
35 8<br />
S-<strong>LAS</strong> (15 x 10 cpm) was administered topically, once, onto the back skin<br />
of rats and guinea pigs. Absorption and distribution in major organs and<br />
blood were studied. Urine was collected 24 hours after topical application of<br />
the test substance. In the guinea pig, the amount of 35 S excreted in the urine<br />
was about 0.1% of the total administered dose. Organ distribution in the rat<br />
was about 5 times greater than in the guinea pig, and "relatively large<br />
amounts" of 35 S were noted in the liver and kidneys. Conclusion states that:<br />
"when 0.2 to 0.5% <strong>LAS</strong> was topically applied once, approximately 0.1 to<br />
0.6% was absorbed"; there was no accumulation in specific organs; the "test<br />
chemical was quickly excreted in the urine after being metabolized".<br />
<strong>UNEP</strong> PUBLICATIONS 303